Table 3.
The clinical difference of RBD+ vs RBD− patients while RBDSQ cutoff at 7, 6 and 5 in present study
| 7 score | 6 score | 5 score | |
|---|---|---|---|
| RBD incidence, n (%) | 24 (17.02) | 30 (21.28) | 37 (26.24) |
| Age | – | – | – |
| PD duration | – | – | – |
| Gender | – | – | – |
| Dopamine use | – | – | – |
| Hypnosmia | – | – | – |
| Freezing | – | – | – |
| Hallucination | + | + | – |
| Constipation | + | + | + |
| HAMA | + | + | + |
| HAMD | + | + | + |
| PDSS | + | + | + |
| MMSE | + | + | + |
| Orthostatic hypotension | + | + | + |
| UPDRS III (total) | – | – | – |
| Bradykinesia (23–26) | – | – | – |
| LcompareA | – | – | – |
| RcompareT | – | – | – |
If the cut off score was set at 7, 6, or 5, the clinical features had little difference. If the cut off score was set at 5 score, the hallucination rates would have no difference in two groups instead. The other features were same in the three condition